downside of glp 1 drugs Why GLP-1 Alone Aren't Enough for Sustainable Weight Loss – STAAR LABS FAQ of the Month: Is
Description
Hence, the rising prevalence of obesity is likely to affect market growth by increasing the demand for GLP-1 receptor agonists
Nauck MA, Meininger G, Sheng D, et al
These necessitate careful patient selection, comprehensive monitoring, and risk mitigation strategies [4,201,202]
These are described above and below
